Literature DB >> 7782536

Differential expression of IL-1 beta, TNF-alpha, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from different microbes.

S Agarwal1, N P Piesco, L P Johns, A E Riccelli.   

Abstract

Macrophages respond to bacterial lipopolysaccharides (LPS) and activate several host defense functions through production of mediators. However, it is not clear whether the degree of macrophage responsiveness to different sources of LPS is equivalent to or varies with the source of LPS. Therefore, in this report, we examined the extent of the human monocyte response to LPS derived from two oral pathogens, Actinobacillus actinomycetemcomitans (Aa) and Porphyromonas gingivalis (Pg). Additionally, due to its well-established ability to activate monocytes, we used LPS from Escherichia coli (Ec). Human monocytes, when activated with a specific source of LPS, exhibited rapid expression of mRNA for IL-1 beta, TNF-alpha, and IL-8, which was followed by IL-6, as measured by RNA-PCR. Moreover, the expression of mRNA for these cytokines was followed by cytokine synthesis. Monocytes from the same subject, when activated with LPS from Pg, Aa, or Ec expressed quantitatively different levels of mRNA and proteins for all four cytokines. A given LPS induced either high or low expression of the battery of cytokines tested, indicating that the expression of these pro-inflammatory cytokines may be regulated by a single or a cluster of gene(s). However, no apparent differences in the time course of mRNA expression for these cytokines were observed in response to any of the LPS tested. Furthermore, the relative ability of the different sources of LPS to induce mRNA for cytokines varied throughout a wide range of LPS concentrations. This suggests that differences exist in the sensitivity of monocytes to a specific LPS, rather than in the kinetics of the secretory process itself.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782536     DOI: 10.1177/00220345950740040501

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  31 in total

1.  Actinobacillus actinomycetemcomitans serotype b-specific polysaccharide antigen stimulates production of chemotactic factors and inflammatory cytokines by human monocytes.

Authors:  N Yamaguchi; Y Yamashita; D Ikeda; T Koga
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages.

Authors:  Joseph Brown; Mark A Wallet; Bryan Krastins; David Sarracino; Maureen M Goodenow
Journal:  J Leukoc Biol       Date:  2010-04       Impact factor: 4.962

3.  Hemoglobin receptor protein from Porphyromonas gingivalis induces interleukin-8 production in human gingival epithelial cells through stimulation of the mitogen-activated protein kinase and NF-κB signal transduction pathways.

Authors:  Yuki Fujita; Masaaki Nakayama; Mariko Naito; Eiki Yamachika; Tetsuyoshi Inoue; Koji Nakayama; Seiji Iida; Naoya Ohara
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

4.  Possible lethal enhancement of toxins from putative periodontopathogens by nicotine: implications for periodontal disease.

Authors:  N M Sayers; B P Gomes; D B Drucker; A S Blinkhorn
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

Review 5.  Macrophages in neuroinflammation: role of the renin-angiotensin-system.

Authors:  Anna Hammer; Johannes Stegbauer; Ralf A Linker
Journal:  Pflugers Arch       Date:  2017-02-11       Impact factor: 3.657

6.  Actinobacillus actinomycetemcomitans Y4 capsular polysaccharide induces IL-1beta mRNA expression through the JNK pathway in differentiated THP-1 cells.

Authors:  T Iwata; A Mitani; Y Ishihara; S Tanaka; G Yamamoto; T Kikuchi; T Naganawa; Y Matsumura; T Suga; M Koide; T Sobue; T Suzuki; T Noguchi
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

7.  Xylitol inhibits inflammatory cytokine expression induced by lipopolysaccharide from Porphyromonas gingivalis.

Authors:  Su-Ji Han; So-Yeon Jeong; Yun-Ju Nam; Kyu-Ho Yang; Hoi-Soon Lim; Jin Chung
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

8.  Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.

Authors:  F Zhou; B Ciric; G-X Zhang; A Rostami
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

9.  Identification of proteins differentially expressed in human monocytes exposed to Porphyromonas gingivalis and its purified components by high-throughput immunoblotting.

Authors:  Qingde Zhou; Salomon Amar
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

10.  Tumor necrosis factor alpha enhances Actinobacillus actinomycetemcomitans leukotoxin-induced HL-60 cell apoptosis by stimulating lymphocyte function-associated antigen 1 expression.

Authors:  Noboru Yamaguchi; Chie Kubo; Yoshikazu Masuhiro; Edward T Lally; Toshihiko Koga; Shigemasa Hanazawa
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.